President of Uzbekistan approves measures to strengthen control over digital product labeling
Tashkent, Uzbekistan (UzDaily.com) — On 23 May, President Shavkat Mirziyoyev signed a resolution aimed at enhancing the efficiency of the digital product labeling system.
The document introduces comprehensive measures to ensure transparency in the movement of labeled goods and to curb shadow production and circulation of counterfeit products.
Under the new regulations, payment for labeling codes will no longer be made in advance but only after the codes have been applied to the products. At the same time, the labeling system operator — CRPT Turon — will provide codes for aggregation purposes free of charge.
The previously existing 90-day deadline for using purchased labeling codes has also been canceled. Now, if codes remain unused, the amount paid will be credited toward future purchases.
To ensure proper control over compliance with the established requirements, an interregional inspection unit will be established within the Tax Committee. Its task will be to monitor all stages of labeled product circulation and to conduct pilot projects for introducing labeling in new product categories.
Starting July 1, wholesale settlements for labeled goods must be made exclusively via cashless payments through bank accounts. Violations of labeling rules from September 1, 2025, will be classified as “high” tax risk factors.
Moreover, without labeling, issuing electronic invoices will be prohibited. In retail trade, a cash receipt can only be generated after scanning (or entering) the labeling code.
From 1 January 2026, tax authorities will be granted the right to conduct remote inspections aimed at identifying violations in the digital labeling sphere. These inspections will not require prior authorization.
The penalty system for non-compliance will also be tightened. The first two violations will result in warnings. If deficiencies are not remedied, fines will be imposed based on a percentage of the net revenue for the last reporting quarter:
First violation within a month: 0.2% of revenue;
Repeat violation within a year: 0.4%;
Third violation: 1%;
Each subsequent violation: 2%.
A separate section of the resolution addresses the regulation of pharmaceutical circulation. From July 1, 2025, the right to sell imported medicines will be granted only to importing companies and their official distributors.
New licensing requirements for pharmaceutical activities, including retail sale of medicines and medical devices, will take effect on 1 September. All newly established companies will be required to register lease or gratuitous use agreements for their premises.
One mandatory condition will be the acceptance of electronic payments for medicines. The Ministry of Health and the Tax Committee have been tasked with establishing an information exchange mechanism on these new requirements by the end of July.
If facts of purchase, storage, transport, or sale of counterfeit or unlabeled medicines are detected, the authorized body will have the right to suspend the pharmacy’s license. Tax authorities may initiate this measure based on inspection results.
At the same time, the deadline for mandatory implementation of the aggregation system for manufacturers of medicines and medical devices has been extended to 1 October 2025.